Search research articles
Contact Us
Filters
Showing results (131-140 of 226) with videos related to
Page
of 23
Sort By:
Biochemical and Biophysical Research Communications
|
September 13, 2023
AXL receptor tyrosine kinase inhibition improves the anti-tumor effects of CD8<sup>+</sup> T cells by inducing CD103<sup>+</sup> dendritic cell-mediated T cell priming
Kyungtaek Im, Yun Jung Choi, Dong Ha Kim, et al.
Cancer Chemotherapy and Pharmacology
|
November 19, 2009
Combined inhibition of IGFR enhances the effects of gefitinib in H1650: a lung cancer cell line with EGFR mutation and primary resistance to EGFR-TK inhibitors
Yun Jung Choi, Jin Kyung Rho, Byung-suk Jeon, et al.
BMC Medical Informatics and Decision Making
|
January 7, 2023
Stratifying non-small cell lung cancer patients using an inverse of the treatment decision rules: validation using electronic health records with application to an administrative database
Min-Hyung Kim, Sojung Park, Yu Rang Park, et al.
Oncology Research
|
June 8, 2010
Prognostic value of E-cadherin expression in non-small cell lung cancer treated with gefitinib
Eun Hee Kook, Yeo Myeong Kim, Hyeon Tae Kim, et al.
Journal of Cancer Research and Therapeutics
|
April 14, 2016
Epidermal growth factor receptor mutations and brain metastasis in patients with nonadenocarcinoma of the lung
Dong-Yeop Shin, Dae Ho Lee, Cheol Hyeon Kim, et al.
Cancer Research
|
July 2, 2009
Depletion of embryonic stem cell signature by histone deacetylase inhibitor in NCCIT cells: involvement of Nanog suppression
Jueng Soo You, Jae Ku Kang, Dong-Wan Seo, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 6, 2007
The survival outcomes of patients with resected non-small cell lung cancer differ according to EGFR mutations and the P21 expression
Im Il Na, Jin Kyung Rho, Yun Jung Choi, et al.
Journal of Cancer Research and Clinical Oncology
|
September 22, 2022
Central nervous systemic efficacy of immune checkpoint inhibitors and concordance between intra/extracranial response in non-small cell lung cancer patients with brain metastasis
Sora Kang, Hyehyun Jeong, Ji Eun Park, et al.
JMIR Mhealth and Uhealth
|
June 23, 2019
Mobile Health Management Platform-Based Pulmonary Rehabilitation for Patients With Non-Small Cell Lung Cancer: Prospective Clinical Trial
Wonjun Ji, Hee Kwon, Sungin Lee, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
March 7, 2019
CDK7 inhibition as a promising therapeutic strategy for lung squamous cell carcinomas with a SOX2 amplification
Jae Young Hur, Hyeong Ryul Kim, Jung Yeon Lee, et al.
Page
of 23
Search research articles
Search
Showing results (131-140 of 226) with videos related to
Sort By:
Page
of 23
Biochemical and Biophysical Research Communications
|
September 13, 2023
AXL receptor tyrosine kinase inhibition improves the anti-tumor effects of CD8<sup>+</sup> T cells by inducing CD103<sup>+</sup> dendritic cell-mediated T cell priming
Kyungtaek Im, Yun Jung Choi, Dong Ha Kim, et al.
Cancer Chemotherapy and Pharmacology
|
November 19, 2009
Combined inhibition of IGFR enhances the effects of gefitinib in H1650: a lung cancer cell line with EGFR mutation and primary resistance to EGFR-TK inhibitors
Yun Jung Choi, Jin Kyung Rho, Byung-suk Jeon, et al.
BMC Medical Informatics and Decision Making
|
January 7, 2023
Stratifying non-small cell lung cancer patients using an inverse of the treatment decision rules: validation using electronic health records with application to an administrative database
Min-Hyung Kim, Sojung Park, Yu Rang Park, et al.
Oncology Research
|
June 8, 2010
Prognostic value of E-cadherin expression in non-small cell lung cancer treated with gefitinib
Eun Hee Kook, Yeo Myeong Kim, Hyeon Tae Kim, et al.
Journal of Cancer Research and Therapeutics
|
April 14, 2016
Epidermal growth factor receptor mutations and brain metastasis in patients with nonadenocarcinoma of the lung
Dong-Yeop Shin, Dae Ho Lee, Cheol Hyeon Kim, et al.
Cancer Research
|
July 2, 2009
Depletion of embryonic stem cell signature by histone deacetylase inhibitor in NCCIT cells: involvement of Nanog suppression
Jueng Soo You, Jae Ku Kang, Dong-Wan Seo, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 6, 2007
The survival outcomes of patients with resected non-small cell lung cancer differ according to EGFR mutations and the P21 expression
Im Il Na, Jin Kyung Rho, Yun Jung Choi, et al.
Journal of Cancer Research and Clinical Oncology
|
September 22, 2022
Central nervous systemic efficacy of immune checkpoint inhibitors and concordance between intra/extracranial response in non-small cell lung cancer patients with brain metastasis
Sora Kang, Hyehyun Jeong, Ji Eun Park, et al.
JMIR Mhealth and Uhealth
|
June 23, 2019
Mobile Health Management Platform-Based Pulmonary Rehabilitation for Patients With Non-Small Cell Lung Cancer: Prospective Clinical Trial
Wonjun Ji, Hee Kwon, Sungin Lee, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
March 7, 2019
CDK7 inhibition as a promising therapeutic strategy for lung squamous cell carcinomas with a SOX2 amplification
Jae Young Hur, Hyeong Ryul Kim, Jung Yeon Lee, et al.
Page
of 23